

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.45249674 |
| 2 | complement activation, alternative pathway (GO:0006957) | 3.97182961 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.74828184 |
| 4 | lysine metabolic process (GO:0006553) | 3.60364722 |
| 5 | lysine catabolic process (GO:0006554) | 3.60364722 |
| 6 | sarcomere organization (GO:0045214) | 3.58618416 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.55381899 |
| 8 | regulation of fibrinolysis (GO:0051917) | 3.50862855 |
| 9 | regulation of apoptotic cell clearance (GO:2000425) | 3.48111482 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.39727193 |
| 11 | protein carboxylation (GO:0018214) | 3.39727193 |
| 12 | cardiac myofibril assembly (GO:0055003) | 3.39159734 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 3.35560369 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.35242016 |
| 15 | phospholipid efflux (GO:0033700) | 3.32122433 |
| 16 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31002144 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25901040 |
| 18 | carnitine shuttle (GO:0006853) | 3.24746486 |
| 19 | regulation of protein activation cascade (GO:2000257) | 3.24042587 |
| 20 | cell communication involved in cardiac conduction (GO:0086065) | 3.23622084 |
| 21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.22290286 |
| 22 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.19752621 |
| 23 | cell communication by electrical coupling (GO:0010644) | 3.17695992 |
| 24 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16992156 |
| 25 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16992156 |
| 26 | regulation of complement activation (GO:0030449) | 3.15405973 |
| 27 | cardiac muscle contraction (GO:0060048) | 3.04350850 |
| 28 | aspartate family amino acid catabolic process (GO:0009068) | 3.03993838 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 3.03847335 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 3.03630183 |
| 31 | acute-phase response (GO:0006953) | 3.01527136 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.00377031 |
| 33 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.99899281 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 2.98051234 |
| 35 | cholesterol efflux (GO:0033344) | 2.97788944 |
| 36 | myofibril assembly (GO:0030239) | 2.96213902 |
| 37 | glyoxylate metabolic process (GO:0046487) | 2.94666873 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.93444295 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92769785 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 2.92675153 |
| 41 | macromolecular complex remodeling (GO:0034367) | 2.92675153 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 2.92675153 |
| 43 | low-density lipoprotein particle remodeling (GO:0034374) | 2.88649094 |
| 44 | negative regulation of cell size (GO:0045792) | 2.86192625 |
| 45 | cell-cell junction maintenance (GO:0045217) | 2.85647344 |
| 46 | fibrinolysis (GO:0042730) | 2.83601618 |
| 47 | protein-lipid complex assembly (GO:0065005) | 2.83520389 |
| 48 | epoxygenase P450 pathway (GO:0019373) | 2.83198868 |
| 49 | muscle filament sliding (GO:0030049) | 2.79766165 |
| 50 | actin-myosin filament sliding (GO:0033275) | 2.79766165 |
| 51 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77559601 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 2.76306915 |
| 53 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.76123969 |
| 54 | acetyl-CoA metabolic process (GO:0006084) | 2.72437783 |
| 55 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71278203 |
| 56 | sodium ion export (GO:0071436) | 2.70682201 |
| 57 | regulation of cholesterol storage (GO:0010885) | 2.69511586 |
| 58 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.69477538 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.68981028 |
| 60 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.68761536 |
| 61 | plasma lipoprotein particle assembly (GO:0034377) | 2.66306219 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 2.64465219 |
| 63 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.64345188 |
| 64 | regulation of skeletal muscle contraction (GO:0014819) | 2.63342435 |
| 65 | tricarboxylic acid cycle (GO:0006099) | 2.62951498 |
| 66 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.60734678 |
| 67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.60244767 |
| 68 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.59392321 |
| 69 | cardiac muscle cell development (GO:0055013) | 2.58078666 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 2.57002753 |
| 71 | actomyosin structure organization (GO:0031032) | 2.56506531 |
| 72 | regulation of membrane repolarization (GO:0060306) | 2.56069735 |
| 73 | kynurenine metabolic process (GO:0070189) | 2.55963960 |
| 74 | protein-lipid complex subunit organization (GO:0071825) | 2.55963185 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 2.54229808 |
| 76 | regulation of fatty acid oxidation (GO:0046320) | 2.53901504 |
| 77 | regulation of p38MAPK cascade (GO:1900744) | 2.53806244 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 2.52862770 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52595505 |
| 80 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.51196724 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.50428131 |
| 82 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.49170088 |
| 83 | glycogen catabolic process (GO:0005980) | 2.49018645 |
| 84 | L-phenylalanine metabolic process (GO:0006558) | 2.48232617 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.48232617 |
| 86 | virion attachment to host cell (GO:0019062) | 2.48206150 |
| 87 | adhesion of symbiont to host cell (GO:0044650) | 2.48206150 |
| 88 | positive regulation of steroid metabolic process (GO:0045940) | 2.46979109 |
| 89 | reverse cholesterol transport (GO:0043691) | 2.46948007 |
| 90 | striated muscle contraction (GO:0006941) | 2.46493341 |
| 91 | protein activation cascade (GO:0072376) | 2.46291571 |
| 92 | cardiac cell development (GO:0055006) | 2.45677858 |
| 93 | L-phenylalanine catabolic process (GO:0006559) | 2.45549342 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45549342 |
| 95 | plasma lipoprotein particle organization (GO:0071827) | 2.45300568 |
| 96 | cell junction maintenance (GO:0034331) | 2.44733440 |
| 97 | carnitine transmembrane transport (GO:1902603) | 2.43621381 |
| 98 | negative regulation of hemostasis (GO:1900047) | 2.43574938 |
| 99 | negative regulation of blood coagulation (GO:0030195) | 2.43574938 |
| 100 | amino-acid betaine transport (GO:0015838) | 2.43288745 |
| 101 | carnitine transport (GO:0015879) | 2.43288745 |
| 102 | complement activation (GO:0006956) | 2.42761617 |
| 103 | positive regulation of cholesterol efflux (GO:0010875) | 2.42375238 |
| 104 | creatine metabolic process (GO:0006600) | 2.41934156 |
| 105 | glutamate metabolic process (GO:0006536) | 2.41756400 |
| 106 | negative regulation of lipid transport (GO:0032369) | 2.41465317 |
| 107 | adhesion of symbiont to host (GO:0044406) | 2.41194368 |
| 108 | phospholipid homeostasis (GO:0055091) | 2.40421136 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40217547 |
| 110 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40171819 |
| 111 | glycolipid catabolic process (GO:0019377) | 2.39558939 |
| 112 | locomotory exploration behavior (GO:0035641) | 2.39315263 |
| 113 | complement activation, classical pathway (GO:0006958) | 2.39205745 |
| 114 | adult heart development (GO:0007512) | 2.38703164 |
| 115 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.37361396 |
| 116 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.35377278 |
| 117 | positive regulation of fatty acid oxidation (GO:0046321) | 2.35239286 |
| 118 | sulfur amino acid catabolic process (GO:0000098) | 2.34976215 |
| 119 | glucan catabolic process (GO:0009251) | 2.33665766 |
| 120 | tricarboxylic acid metabolic process (GO:0072350) | 2.32824899 |
| 121 | establishment of nucleus localization (GO:0040023) | 2.32452494 |
| 122 | layer formation in cerebral cortex (GO:0021819) | 2.32073302 |
| 123 | regulation of plasminogen activation (GO:0010755) | 2.31404979 |
| 124 | regulation of synapse structural plasticity (GO:0051823) | 2.31233415 |
| 125 | fatty acid beta-oxidation (GO:0006635) | 2.30961173 |
| 126 | alanine transport (GO:0032328) | 2.30329899 |
| 127 | low-density lipoprotein particle clearance (GO:0034383) | 2.29486800 |
| 128 | omega-hydroxylase P450 pathway (GO:0097267) | 2.29020171 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28773873 |
| 130 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.28558365 |
| 131 | cardiac muscle hypertrophy (GO:0003300) | 2.27770574 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 2.27616668 |
| 133 | response to mercury ion (GO:0046689) | 2.27571954 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27307857 |
| 135 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.26803973 |
| 136 | actin-mediated cell contraction (GO:0070252) | 2.26762805 |
| 137 | 4-hydroxyproline metabolic process (GO:0019471) | 2.26519934 |
| 138 | negative regulation of fibrinolysis (GO:0051918) | 2.26384774 |
| 139 | ethanol oxidation (GO:0006069) | 2.26120162 |
| 140 | oligosaccharide catabolic process (GO:0009313) | 2.25981415 |
| 141 | positive regulation of lipid storage (GO:0010884) | 2.25829366 |
| 142 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.25268082 |
| 143 | activation of MAPKKK activity (GO:0000185) | 2.25021804 |
| 144 | ketone body metabolic process (GO:1902224) | 2.23619401 |
| 145 | positive regulation of sodium ion transport (GO:0010765) | 2.23051364 |
| 146 | short-chain fatty acid metabolic process (GO:0046459) | 2.22945792 |
| 147 | semaphorin-plexin signaling pathway (GO:0071526) | 2.22932354 |
| 148 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.22724054 |
| 149 | nucleobase catabolic process (GO:0046113) | 2.22410232 |
| 150 | urea metabolic process (GO:0019627) | 2.22338513 |
| 151 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.22090474 |
| 152 | negative regulation of coagulation (GO:0050819) | 2.22057826 |
| 153 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.21841520 |
| 154 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.21790252 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.21637932 |
| 156 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.21160070 |
| 157 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21037737 |
| 158 | striated muscle hypertrophy (GO:0014897) | 2.20997664 |
| 159 | negative regulation of sterol transport (GO:0032372) | 2.20963239 |
| 160 | negative regulation of cholesterol transport (GO:0032375) | 2.20963239 |
| 161 | diacylglycerol metabolic process (GO:0046339) | 2.20577645 |
| 162 | cellular polysaccharide catabolic process (GO:0044247) | 2.18767587 |
| 163 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.18723652 |
| 164 | macroautophagy (GO:0016236) | 2.18480726 |
| 165 | cardiac muscle cell action potential (GO:0086001) | 2.18460966 |
| 166 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.18201306 |
| 167 | mannose metabolic process (GO:0006013) | 2.18102523 |
| 168 | positive regulation of blood coagulation (GO:0030194) | 2.18033919 |
| 169 | positive regulation of hemostasis (GO:1900048) | 2.18033919 |
| 170 | lipoprotein metabolic process (GO:0042157) | 2.17777408 |
| 171 | fructose metabolic process (GO:0006000) | 2.17393042 |
| 172 | potassium ion import (GO:0010107) | 2.16681711 |
| 173 | fatty acid homeostasis (GO:0055089) | 2.16246466 |
| 174 | blood coagulation, intrinsic pathway (GO:0007597) | 2.16083327 |
| 175 | positive regulation of coagulation (GO:0050820) | 2.16068328 |
| 176 | regulation of extracellular matrix organization (GO:1903053) | 2.14718713 |
| 177 | regulation of extracellular matrix disassembly (GO:0010715) | 2.13440181 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.13260267 |
| 179 | activation of protein kinase A activity (GO:0034199) | 2.12559394 |
| 180 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.12131721 |
| 181 | positive regulation of glycogen metabolic process (GO:0070875) | 2.11240181 |
| 182 | negative regulation of wound healing (GO:0061045) | 2.11080827 |
| 183 | drug catabolic process (GO:0042737) | 2.10525200 |
| 184 | acute inflammatory response (GO:0002526) | 2.10045683 |
| 185 | positive regulation of cholesterol transport (GO:0032376) | 2.08131839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74825377 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.71367758 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56402789 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30895955 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26395310 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23820693 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17155668 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12126317 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06837373 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01256016 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01246100 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90086743 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87678898 |
| 14 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85429230 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80149006 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80149006 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79400414 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78407060 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77143449 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74365369 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.70475179 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68993384 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68351433 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67914591 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64107929 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63356718 |
| 27 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.61194967 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61181369 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60451093 |
| 30 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.58464582 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57469676 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56869221 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56033422 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.53369181 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.53369181 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53177916 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52447868 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.52132730 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51896400 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51293160 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51132896 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49300553 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47840642 |
| 44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.47352085 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45917668 |
| 46 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45518037 |
| 47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.38291990 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36216544 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35461941 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34360342 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32241520 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31770465 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30358486 |
| 54 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29798865 |
| 55 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28076438 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27804858 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27582547 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27062424 |
| 59 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26934360 |
| 60 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25613508 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25311506 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24607963 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22075172 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21722882 |
| 65 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21419847 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20980390 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20918699 |
| 68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19748408 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19586983 |
| 70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17878664 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17464396 |
| 72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15136516 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14892747 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14455585 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12752117 |
| 76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11791617 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11173614 |
| 78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10914733 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08449353 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08281501 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05065052 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04633202 |
| 83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04278680 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03416458 |
| 85 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03275903 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03015296 |
| 87 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02640808 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02453319 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02422388 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01426318 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01226410 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00219692 |
| 93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00128352 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99193135 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99131597 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.97492609 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97126076 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97090296 |
| 99 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96619393 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95078341 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94943717 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94665030 |
| 103 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94252353 |
| 104 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93701209 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92698021 |
| 106 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92484037 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91417625 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90666429 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90096568 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89991428 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89648946 |
| 112 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89546379 |
| 113 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88628433 |
| 114 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88601020 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88399493 |
| 116 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.88090759 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87936758 |
| 118 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87421030 |
| 119 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87130950 |
| 120 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86969162 |
| 121 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86554789 |
| 122 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.85983953 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85879875 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85367436 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84565098 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84078698 |
| 127 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83877905 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83668868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.05243661 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.02553770 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.18714409 |
| 4 | MP0003646_muscle_fatigue | 3.02967223 |
| 5 | MP0003303_peritoneal_inflammation | 2.96322091 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.93285071 |
| 7 | MP0005360_urolithiasis | 2.66833741 |
| 8 | MP0005451_abnormal_body_composition | 2.57027201 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.48995398 |
| 10 | MP0000749_muscle_degeneration | 2.36737140 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.34774267 |
| 12 | MP0004130_abnormal_muscle_cell | 2.26031270 |
| 13 | MP0003879_abnormal_hair_cell | 2.22168393 |
| 14 | MP0005083_abnormal_biliary_tract | 2.21583287 |
| 15 | MP0004858_abnormal_nervous_system | 2.18228304 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.14145559 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.11898177 |
| 18 | MP0005330_cardiomyopathy | 2.03228163 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.00462842 |
| 20 | MP0000747_muscle_weakness | 1.97815618 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 1.87384229 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.86888388 |
| 23 | MP0002269_muscular_atrophy | 1.79887151 |
| 24 | MP0003137_abnormal_impulse_conducting | 1.79876096 |
| 25 | MP0005365_abnormal_bile_salt | 1.76071180 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.75649267 |
| 27 | MP0006082_CNS_inflammation | 1.70104787 |
| 28 | MP0002972_abnormal_cardiac_muscle | 1.65489837 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.63407633 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.57033934 |
| 31 | MP0003329_amyloid_beta_deposits | 1.56916525 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.54263677 |
| 33 | MP0003283_abnormal_digestive_organ | 1.53726635 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.53094554 |
| 35 | MP0009840_abnormal_foam_cell | 1.52456026 |
| 36 | MP0002106_abnormal_muscle_physiology | 1.50607547 |
| 37 | MP0003436_decreased_susceptibility_to | 1.46540562 |
| 38 | MP0003252_abnormal_bile_duct | 1.44562667 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.44342974 |
| 40 | MP0005275_abnormal_skin_tensile | 1.42705755 |
| 41 | MP0004233_abnormal_muscle_weight | 1.41393699 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.41025249 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.37946526 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.37646334 |
| 45 | MP0005409_darkened_coat_color | 1.37060709 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.36495657 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.34235285 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.33487347 |
| 49 | MP0005369_muscle_phenotype | 1.31686075 |
| 50 | MP0005385_cardiovascular_system_phenoty | 1.31214766 |
| 51 | MP0001544_abnormal_cardiovascular_syste | 1.31214766 |
| 52 | MP0000343_altered_response_to | 1.30686107 |
| 53 | MP0000920_abnormal_myelination | 1.29821655 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.29236314 |
| 55 | MP0005166_decreased_susceptibility_to | 1.28606107 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.26233950 |
| 57 | MP0006138_congestive_heart_failure | 1.25615712 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.25477027 |
| 59 | MP0004085_abnormal_heartbeat | 1.25174833 |
| 60 | MP0003690_abnormal_glial_cell | 1.24739434 |
| 61 | MP0005332_abnormal_amino_acid | 1.24055303 |
| 62 | MP0000604_amyloidosis | 1.23064893 |
| 63 | MP0005666_abnormal_adipose_tissue | 1.19809888 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.18760885 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.17947544 |
| 66 | MP0009785_altered_susceptibility_to | 1.14320973 |
| 67 | MP0009764_decreased_sensitivity_to | 1.13810403 |
| 68 | MP0002108_abnormal_muscle_morphology | 1.13327294 |
| 69 | MP0002971_abnormal_brown_adipose | 1.12167047 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.11314893 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.11052818 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.09443727 |
| 73 | MP0003724_increased_susceptibility_to | 1.07516692 |
| 74 | MP0002254_reproductive_system_inflammat | 1.07006290 |
| 75 | MP0000579_abnormal_nail_morphology | 1.05038821 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04976561 |
| 77 | MP0004484_altered_response_of | 1.04461915 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.04452064 |
| 79 | MP0001849_ear_inflammation | 1.01624747 |
| 80 | MP0008004_abnormal_stomach_pH | 1.00871037 |
| 81 | MP0000566_synostosis | 1.00746703 |
| 82 | MP0003123_paternal_imprinting | 0.99910437 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 0.99513946 |
| 84 | MP0003279_aneurysm | 0.99083548 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.97754785 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 0.97717305 |
| 87 | MP0004270_analgesia | 0.96987272 |
| 88 | MP0004510_myositis | 0.94262079 |
| 89 | MP0002419_abnormal_innate_immunity | 0.93702623 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.93666984 |
| 91 | MP0004272_abnormal_basement_membrane | 0.92184252 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.92031066 |
| 93 | MP0000733_abnormal_muscle_development | 0.91466594 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.90559235 |
| 95 | MP0009278_abnormal_bone_marrow | 0.90274846 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.89073333 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.86807228 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.86087409 |
| 99 | MP0000569_abnormal_digit_pigmentation | 0.86016078 |
| 100 | MP0008874_decreased_physiological_sensi | 0.85371768 |
| 101 | MP0003868_abnormal_feces_composition | 0.85114987 |
| 102 | MP0008469_abnormal_protein_level | 0.84160153 |
| 103 | MP0008260_abnormal_autophagy | 0.83599750 |
| 104 | MP0003195_calcinosis | 0.83278372 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.83257009 |
| 106 | MP0004947_skin_inflammation | 0.83045318 |
| 107 | MP0005025_abnormal_response_to | 0.83007718 |
| 108 | MP0001958_emphysema | 0.82067898 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.81496003 |
| 110 | MP0000609_abnormal_liver_physiology | 0.80221768 |
| 111 | MP0003633_abnormal_nervous_system | 0.80060855 |
| 112 | MP0009046_muscle_twitch | 0.79993859 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79826466 |
| 114 | MP0005023_abnormal_wound_healing | 0.79226401 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.79128913 |
| 116 | MP0005670_abnormal_white_adipose | 0.78864427 |
| 117 | MP0005535_abnormal_body_temperature | 0.78474015 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.77255581 |
| 119 | MP0003045_fibrosis | 0.74982260 |
| 120 | MP0002064_seizures | 0.74710407 |
| 121 | MP0002796_impaired_skin_barrier | 0.73628949 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.73581922 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.73295964 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.73168578 |
| 125 | MP0003075_altered_response_to | 0.73020877 |
| 126 | MP0000778_abnormal_nervous_system | 0.72734935 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.72131527 |
| 128 | MP0003634_abnormal_glial_cell | 0.70173571 |
| 129 | MP0005448_abnormal_energy_balance | 0.69614791 |
| 130 | MP0001790_abnormal_immune_system | 0.68433113 |
| 131 | MP0005387_immune_system_phenotype | 0.68433113 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.68211114 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.67651087 |
| 134 | MP0001440_abnormal_grooming_behavior | 0.67175459 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.66836443 |
| 136 | MP0002063_abnormal_learning/memory/cond | 0.66310338 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.64470057 |
| 138 | MP0004043_abnormal_pH_regulation | 0.63856930 |
| 139 | MP0008569_lethality_at_weaning | 0.63350775 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.62926502 |
| 141 | MP0003632_abnormal_nervous_system | 0.62815132 |
| 142 | MP0005423_abnormal_somatic_nervous | 0.62389162 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62306474 |
| 144 | MP0001756_abnormal_urination | 0.62066037 |
| 145 | MP0000467_abnormal_esophagus_morphology | 0.61200980 |
| 146 | MP0003091_abnormal_cell_migration | 0.61123422 |
| 147 | MP0009643_abnormal_urine_homeostasis | 0.60351023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.92355810 |
| 2 | Glomerulonephritis (HP:0000099) | 4.61865984 |
| 3 | Sudden death (HP:0001699) | 4.44673716 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.94478961 |
| 5 | Exercise-induced myalgia (HP:0003738) | 3.92260913 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.88798968 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 3.81903647 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.72749050 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.71368451 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.71368451 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71368451 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.67000671 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.46058595 |
| 14 | Difficulty running (HP:0009046) | 3.44851542 |
| 15 | Increased connective tissue (HP:0009025) | 3.44035374 |
| 16 | Ventricular tachycardia (HP:0004756) | 3.41054031 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 3.25442145 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.18442869 |
| 19 | Joint hemorrhage (HP:0005261) | 3.15906797 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.10100665 |
| 21 | Myoglobinuria (HP:0002913) | 3.09822307 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 3.09224907 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 3.08102232 |
| 24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.07423039 |
| 25 | Nuclear cataract (HP:0100018) | 3.01613589 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.01281286 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.00354125 |
| 28 | Bundle branch block (HP:0011710) | 2.99398164 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 2.93858992 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.83008021 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.83008021 |
| 32 | Hemorrhage of the eye (HP:0011885) | 2.81355069 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81017831 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81017831 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81017831 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 2.80432537 |
| 37 | Lymphangioma (HP:0100764) | 2.79811537 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78010122 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 2.76057484 |
| 40 | Ketoacidosis (HP:0001993) | 2.73198150 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.73126593 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.72402903 |
| 43 | Nephritis (HP:0000123) | 2.68179507 |
| 44 | Amyloidosis (HP:0011034) | 2.67806950 |
| 45 | Atrial fibrillation (HP:0005110) | 2.67592374 |
| 46 | Myotonia (HP:0002486) | 2.67273554 |
| 47 | Ventricular arrhythmia (HP:0004308) | 2.64653886 |
| 48 | Ketosis (HP:0001946) | 2.63992465 |
| 49 | Mutism (HP:0002300) | 2.62177595 |
| 50 | Difficulty climbing stairs (HP:0003551) | 2.61566279 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57705807 |
| 52 | Disinhibition (HP:0000734) | 2.54495716 |
| 53 | Primary atrial arrhythmia (HP:0001692) | 2.51723022 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.51487096 |
| 55 | Abnormality of the Achilles tendon (HP:0005109) | 2.48962672 |
| 56 | Purpura (HP:0000979) | 2.48563215 |
| 57 | Xanthomatosis (HP:0000991) | 2.48225586 |
| 58 | Syncope (HP:0001279) | 2.45354159 |
| 59 | Loss of speech (HP:0002371) | 2.40546839 |
| 60 | Heart block (HP:0012722) | 2.37365321 |
| 61 | Subaortic stenosis (HP:0001682) | 2.36659206 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.36659206 |
| 63 | Atrioventricular block (HP:0001678) | 2.36105522 |
| 64 | Achilles tendon contracture (HP:0001771) | 2.35578112 |
| 65 | Gout (HP:0001997) | 2.34538812 |
| 66 | Supraventricular tachycardia (HP:0004755) | 2.33294713 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.32251453 |
| 68 | Obstructive sleep apnea (HP:0002870) | 2.32001536 |
| 69 | Myocardial infarction (HP:0001658) | 2.31693553 |
| 70 | Supraventricular arrhythmia (HP:0005115) | 2.31541719 |
| 71 | Abnormal atrioventricular conduction (HP:0005150) | 2.30979723 |
| 72 | Prolonged QT interval (HP:0001657) | 2.30793074 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30213247 |
| 74 | Broad metatarsal (HP:0001783) | 2.27292716 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.26792698 |
| 76 | Scapular winging (HP:0003691) | 2.25544704 |
| 77 | Lipoatrophy (HP:0100578) | 2.21489330 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21452878 |
| 79 | Complement deficiency (HP:0004431) | 2.19010900 |
| 80 | Hamartoma of the eye (HP:0010568) | 2.16541680 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.16524554 |
| 82 | Malnutrition (HP:0004395) | 2.16060388 |
| 83 | Nemaline bodies (HP:0003798) | 2.11769506 |
| 84 | Abnormality of the lower motor neuron (HP:0002366) | 2.11196869 |
| 85 | Skin nodule (HP:0200036) | 2.09912603 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 2.09489918 |
| 87 | Upper limb amyotrophy (HP:0009129) | 2.09489918 |
| 88 | Thin bony cortex (HP:0002753) | 2.07761592 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.07174751 |
| 90 | Palpitations (HP:0001962) | 2.06248930 |
| 91 | Frequent falls (HP:0002359) | 2.05885758 |
| 92 | Retinal atrophy (HP:0001105) | 2.05882038 |
| 93 | Hypercholesterolemia (HP:0003124) | 2.05656573 |
| 94 | Mitral stenosis (HP:0001718) | 2.05532745 |
| 95 | Hypoalphalipoproteinemia (HP:0003233) | 2.01409549 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 2.01066903 |
| 97 | Turricephaly (HP:0000262) | 1.99862298 |
| 98 | EMG: neuropathic changes (HP:0003445) | 1.98888498 |
| 99 | Orchitis (HP:0100796) | 1.98156182 |
| 100 | Hypoplastic ischia (HP:0003175) | 1.97636012 |
| 101 | Abnormality of macrophages (HP:0004311) | 1.97329142 |
| 102 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96450012 |
| 103 | Eczematoid dermatitis (HP:0000976) | 1.95962459 |
| 104 | Long toe (HP:0010511) | 1.94650955 |
| 105 | Cholelithiasis (HP:0001081) | 1.93871975 |
| 106 | Dilated cardiomyopathy (HP:0001644) | 1.93754785 |
| 107 | Hyperammonemia (HP:0001987) | 1.92606861 |
| 108 | Pathologic fracture (HP:0002756) | 1.91454487 |
| 109 | Myopathic facies (HP:0002058) | 1.91432781 |
| 110 | Abnormality of the ischium (HP:0003174) | 1.90405266 |
| 111 | Increased serum ferritin (HP:0003281) | 1.88749240 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.88364584 |
| 113 | Muscle stiffness (HP:0003552) | 1.88098655 |
| 114 | Dysmetric saccades (HP:0000641) | 1.87542970 |
| 115 | Rhabdomyolysis (HP:0003201) | 1.87208348 |
| 116 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86917536 |
| 117 | Apathy (HP:0000741) | 1.86546781 |
| 118 | Hyperglycinuria (HP:0003108) | 1.86081956 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86069471 |
| 120 | Aneurysm (HP:0002617) | 1.85360919 |
| 121 | Action tremor (HP:0002345) | 1.84746764 |
| 122 | Intrahepatic cholestasis (HP:0001406) | 1.84399189 |
| 123 | Muscle fiber inclusion bodies (HP:0100299) | 1.83815405 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 1.82809939 |
| 125 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82363512 |
| 126 | Hypolipoproteinemia (HP:0010981) | 1.81916228 |
| 127 | Hypobetalipoproteinemia (HP:0003563) | 1.81849261 |
| 128 | Rapidly progressive (HP:0003678) | 1.80336327 |
| 129 | J-shaped sella turcica (HP:0002680) | 1.80039398 |
| 130 | Optic neuritis (HP:0100653) | 1.79218374 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 1.79218374 |
| 132 | Dementia (HP:0000726) | 1.79157806 |
| 133 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.77710390 |
| 134 | Conjunctival hamartoma (HP:0100780) | 1.77528853 |
| 135 | Bulbar palsy (HP:0001283) | 1.77386555 |
| 136 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76951156 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75036844 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.75036844 |
| 139 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.74755706 |
| 140 | Round ear (HP:0100830) | 1.74054443 |
| 141 | Hypophosphatemia (HP:0002148) | 1.73200136 |
| 142 | Abnormal gallbladder morphology (HP:0012437) | 1.70523033 |
| 143 | Diminished motivation (HP:0000745) | 1.70426861 |
| 144 | Visceral angiomatosis (HP:0100761) | 1.70399292 |
| 145 | Shallow orbits (HP:0000586) | 1.70120719 |
| 146 | Neonatal onset (HP:0003623) | 1.69946470 |
| 147 | Foot dorsiflexor weakness (HP:0009027) | 1.69278353 |
| 148 | Hyperlipoproteinemia (HP:0010980) | 1.69252373 |
| 149 | Back pain (HP:0003418) | 1.68679686 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.68527650 |
| 151 | Pheochromocytoma (HP:0002666) | 1.67436249 |
| 152 | Protuberant abdomen (HP:0001538) | 1.66930133 |
| 153 | Axonal loss (HP:0003447) | 1.66793659 |
| 154 | Abnormal EKG (HP:0003115) | 1.66667317 |
| 155 | Abnormality of the foot musculature (HP:0001436) | 1.65338642 |
| 156 | Abnormality of complement system (HP:0005339) | 1.65147651 |
| 157 | Conjugated hyperbilirubinemia (HP:0002908) | 1.63643725 |
| 158 | Stroke (HP:0001297) | 1.61154540 |
| 159 | Hyperparathyroidism (HP:0000843) | 1.60650071 |
| 160 | Insidious onset (HP:0003587) | 1.59806258 |
| 161 | Termporal pattern (HP:0011008) | 1.59806258 |
| 162 | Hydroxyprolinuria (HP:0003080) | 1.58160346 |
| 163 | Abnormality of proline metabolism (HP:0010907) | 1.58160346 |
| 164 | Esophageal varix (HP:0002040) | 1.57855869 |
| 165 | Hyperacusis (HP:0010780) | 1.57653295 |
| 166 | Vascular calcification (HP:0004934) | 1.57627984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.11331569 |
| 2 | TTN | 3.84171911 |
| 3 | LMTK2 | 3.08040345 |
| 4 | PKN2 | 3.06831199 |
| 5 | PHKG2 | 2.70830025 |
| 6 | PHKG1 | 2.70830025 |
| 7 | IRAK3 | 2.52412107 |
| 8 | RIPK1 | 2.21288949 |
| 9 | SIK1 | 2.05316161 |
| 10 | PDGFRA | 1.76971535 |
| 11 | MAP3K9 | 1.73836175 |
| 12 | ICK | 1.68589837 |
| 13 | OBSCN | 1.67530792 |
| 14 | BCKDK | 1.66837551 |
| 15 | PRPF4B | 1.60886590 |
| 16 | PTK6 | 1.58879022 |
| 17 | ERN1 | 1.57895964 |
| 18 | DMPK | 1.55869094 |
| 19 | NEK1 | 1.55238053 |
| 20 | MAP3K11 | 1.51167414 |
| 21 | PAK6 | 1.50040341 |
| 22 | DAPK2 | 1.49092358 |
| 23 | KSR2 | 1.48950179 |
| 24 | NTRK1 | 1.47513034 |
| 25 | TYRO3 | 1.47380572 |
| 26 | EPHB1 | 1.35973943 |
| 27 | MARK2 | 1.30807303 |
| 28 | EPHB2 | 1.26343913 |
| 29 | MAP3K3 | 1.25154761 |
| 30 | DDR2 | 1.23325320 |
| 31 | TBK1 | 1.21956986 |
| 32 | TAOK2 | 1.20661096 |
| 33 | LATS2 | 1.19347941 |
| 34 | MAP3K7 | 1.18955917 |
| 35 | MAP2K4 | 1.18137893 |
| 36 | CAMKK1 | 1.17291616 |
| 37 | FGR | 1.15446078 |
| 38 | PAK3 | 1.14765346 |
| 39 | RET | 1.13691020 |
| 40 | MINK1 | 1.11864350 |
| 41 | MATK | 1.11819299 |
| 42 | ROCK1 | 1.09571624 |
| 43 | BLK | 1.09014676 |
| 44 | FGFR3 | 1.08153705 |
| 45 | TYK2 | 1.07683468 |
| 46 | PDK3 | 1.05662132 |
| 47 | PDK4 | 1.05662132 |
| 48 | GRK7 | 1.04247064 |
| 49 | STK38 | 1.03627344 |
| 50 | MYLK | 1.03479678 |
| 51 | EPHA2 | 1.03035141 |
| 52 | FGFR4 | 1.02837840 |
| 53 | MAP3K4 | 0.99501412 |
| 54 | MAP2K6 | 0.99194016 |
| 55 | WNK4 | 0.98989600 |
| 56 | PTK2 | 0.98277733 |
| 57 | CAMK1G | 0.98250215 |
| 58 | MAP2K3 | 0.97494285 |
| 59 | BMX | 0.97323588 |
| 60 | PRKD3 | 0.97294535 |
| 61 | KSR1 | 0.94324253 |
| 62 | SGK494 | 0.92415661 |
| 63 | SGK223 | 0.92415661 |
| 64 | MAP3K6 | 0.92235398 |
| 65 | NTRK3 | 0.91500100 |
| 66 | MARK1 | 0.90620845 |
| 67 | NTRK2 | 0.89994323 |
| 68 | PINK1 | 0.88635844 |
| 69 | CAMK1D | 0.87587214 |
| 70 | FER | 0.87573714 |
| 71 | LATS1 | 0.86181262 |
| 72 | ERBB2 | 0.82215939 |
| 73 | NME2 | 0.81477220 |
| 74 | EEF2K | 0.81214887 |
| 75 | CSK | 0.79785805 |
| 76 | ABL2 | 0.78714515 |
| 77 | PRKD1 | 0.76847066 |
| 78 | CDC42BPA | 0.76520947 |
| 79 | FGFR2 | 0.76516572 |
| 80 | MOS | 0.72736976 |
| 81 | SGK2 | 0.72088486 |
| 82 | EPHA4 | 0.71718655 |
| 83 | MAP3K13 | 0.71451223 |
| 84 | PRKAA1 | 0.70846812 |
| 85 | MAP3K2 | 0.70790779 |
| 86 | TESK1 | 0.70615626 |
| 87 | TAOK1 | 0.70545672 |
| 88 | ROCK2 | 0.69237040 |
| 89 | MAP3K14 | 0.69040786 |
| 90 | PDGFRB | 0.67666212 |
| 91 | MAP3K10 | 0.67056108 |
| 92 | INSRR | 0.66748748 |
| 93 | CAMK4 | 0.65820889 |
| 94 | PRKD2 | 0.65461340 |
| 95 | CAMK2G | 0.65187380 |
| 96 | MAPKAPK3 | 0.63576666 |
| 97 | TNK2 | 0.63278185 |
| 98 | MAPK12 | 0.63053517 |
| 99 | MAPK4 | 0.62972246 |
| 100 | DYRK1B | 0.61715276 |
| 101 | RPS6KC1 | 0.61505940 |
| 102 | RPS6KL1 | 0.61505940 |
| 103 | MST1R | 0.59653215 |
| 104 | WNK1 | 0.59076047 |
| 105 | PIK3CA | 0.58930450 |
| 106 | STK11 | 0.58718663 |
| 107 | PDPK1 | 0.58650770 |
| 108 | MAP2K1 | 0.57809771 |
| 109 | PRKCH | 0.57735864 |
| 110 | RPS6KA2 | 0.57482581 |
| 111 | UHMK1 | 0.57299428 |
| 112 | PDK1 | 0.56156636 |
| 113 | SGK3 | 0.56105484 |
| 114 | MTOR | 0.55223607 |
| 115 | PKN1 | 0.55083705 |
| 116 | PIM2 | 0.54947026 |
| 117 | CDK5 | 0.54174789 |
| 118 | STK39 | 0.53877140 |
| 119 | JAK1 | 0.53071453 |
| 120 | PAK4 | 0.52630228 |
| 121 | RIPK4 | 0.52577338 |
| 122 | PAK2 | 0.51043055 |
| 123 | PIK3CG | 0.50117176 |
| 124 | DAPK3 | 0.50058464 |
| 125 | CHUK | 0.50038185 |
| 126 | CSF1R | 0.49962709 |
| 127 | CASK | 0.49758287 |
| 128 | PRKAA2 | 0.49744681 |
| 129 | MAPK7 | 0.49602849 |
| 130 | LRRK2 | 0.49596581 |
| 131 | MAP3K1 | 0.48411920 |
| 132 | SIK2 | 0.48411470 |
| 133 | PRKG2 | 0.48102894 |
| 134 | IRAK2 | 0.47421952 |
| 135 | ZAP70 | 0.45894392 |
| 136 | TGFBR2 | 0.43964161 |
| 137 | ILK | 0.43385838 |
| 138 | JAK2 | 0.41793327 |
| 139 | CAMK2D | 0.41720455 |
| 140 | PRKCZ | 0.40336017 |
| 141 | PRKACG | 0.39842009 |
| 142 | PDK2 | 0.39689793 |
| 143 | GSK3A | 0.39386084 |
| 144 | EPHA3 | 0.38752012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31201498 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.79087410 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76503419 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69318188 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29713948 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18675914 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18507194 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84292941 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83406609 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80489443 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80084994 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79881747 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76326217 |
| 14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.71637542 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70678199 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.64498084 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.55143165 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54957264 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53651633 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.52912218 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49270538 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48495910 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45294038 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.43145836 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41469980 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40948734 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32661174 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31929064 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31881754 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25685902 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22371335 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18869595 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18331516 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17363907 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16347532 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10493970 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08821593 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05443371 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.03784042 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99673161 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97342521 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 0.93618211 |
| 43 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90260930 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90127578 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85798759 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85554276 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85510488 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85069449 |
| 49 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84407237 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84161637 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83700323 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 0.83533152 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83122571 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82555773 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81242550 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.81216920 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80905706 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.80838640 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.79860288 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77851398 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76729038 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.74553426 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74405751 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.72786353 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72753769 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70789610 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70067777 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70000337 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69833735 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68397443 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67978628 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67846998 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67133856 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66418978 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65674065 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65588891 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.65180535 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64702419 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63763192 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.63059525 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62695514 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.62651774 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62518361 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.62500149 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62139775 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60835586 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60806841 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60307718 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.59019688 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58176183 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.57837856 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57349648 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56950319 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.56625783 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55860517 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55602424 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.55277220 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55217496 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54908161 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54399094 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52084304 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.52039064 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.52019548 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51955979 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51783172 |
| 106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51257223 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.51066243 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50641154 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50620884 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.50440324 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50095001 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50080370 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49688319 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49587875 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49474758 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.49239899 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48936291 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48334700 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48129694 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47967696 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47832270 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47377125 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46132090 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46051425 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45905482 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45386720 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45212264 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45201340 |
| 129 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44904185 |
| 130 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43340859 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43101735 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40101605 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39417108 |
| 134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38679313 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38566381 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38322613 |
| 137 | Adherens junction_Homo sapiens_hsa04520 | 0.38060080 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36642964 |
| 139 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36620107 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36021757 |
| 141 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35595040 |
| 142 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34778720 |
| 143 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33303514 |

